Epstein–Barr Virus Positivity as a Biomarker in First-Line Chemoimmunotherapy for Gastric Cancer
Journal of Gastric Cancer · 2027 · 27
DOI: 10.5230/jgc.2027.27.e1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastric Cancer, 2027. Verfasst von Dongwoo Cho und 13 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul St. Mary's Hospital, The Catholic University of Korea.
Abstract (Originalsprache)
Purpose Epstein–Barr virus (EBV)-associated gastric cancer (EBVaGC), which is characterized by an inflamed tumor microenvironment, may represent a relevant subgroup in the setting of immune checkpoint inhibitor (ICI)-based therapy. We evaluated whether EBV positivity identifies a distinct subgroup of gastric cancer in patients receiving first-line chemoimmunotherapy and determined its association with programmed death-ligand 1 (PD-L1) expression and microsatellite instability.
Förderung
- Seoul St. Mary's Hospital, The Catholic University of Korea
Zitieren
APA
Cho, D., Kim, S., Park, S. J., Shin, K., Lee, M., Kim, H., Lee, H. Y., Kim, S., Sun, D., Lee, J. H., Lee, K., Yang, Y., Park, J., & Kim, I. (2027). Epstein–Barr Virus Positivity as a Biomarker in First-Line Chemoimmunotherapy for Gastric Cancer. Journal of Gastric Cancer, 27. https://doi.org/10.5230/jgc.2027.27.e1
Vancouver
Cho D, Kim S, Park SJ, Shin K, Lee M, Kim H, et al. Epstein–Barr Virus Positivity as a Biomarker in First-Line Chemoimmunotherapy for Gastric Cancer. Journal of Gastric Cancer. 2027;27. doi:10.5230/jgc.2027.27.e1
BibTeX
@article{Cho2027,
author = {Cho, Dongwoo and Kim, Seunghan and Park, Se Jun and Shin, Kabsoo and Lee, MyungAh and Kim, Hyunho and Lee, Hee Yeon and Kim, Seoree and Sun, Der-Sheng and Lee, Ji Hyun and Lee, Kwonjae and Yang, Youngjun and Park, Juyeon and Kim, In-Ho},
title = {Epstein–Barr Virus Positivity as a Biomarker in First-Line Chemoimmunotherapy for Gastric Cancer},
journal = {Journal of Gastric Cancer},
year = {2027},
volume = {27},
doi = {10.5230/jgc.2027.27.e1}
}
EUVIMED